Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients —a prospective cohort study
ConclusionWe found significant higher levels of serum suPAR in ARDS patients compared to those not fulfilling ARDS criteria. Serum and BALF-suPAR were significantly higher in those patients with evidence for invasive pulmonary aspergillosis. These findings may suggest testing this biomarker for early diagnosis of fungal infection in a greater cohort.
Source: Infection - Category: Infectious Diseases Source Type: research
More News: Aspergillosis | Austria Health | Bronchoscopy | Fungal Infections | Infectious Diseases | Internal Medicine | Respiratory Medicine | Study